Intended for healthcare professionals

Editor's Choice

Non-alcoholic fatty liver disease

BMJ 2011; 343 doi: https://doi.org/10.1136/bmj.d4652 (Published 20 July 2011) Cite this as: BMJ 2011;343:d4652
  1. Fiona Godlee, editor, BMJ
  1. fgodlee{at}bmj.com

What do you know about non-alcoholic fatty liver disease (NAFLD)? Almost nothing, in my case, until I read the two articles on the subject in this week’s BMJ (doi:10.1136/bmj.d3897, doi:10.1136/bmj.d4460). Perhaps anyone in the same boat can be forgiven. As explained in a review article just published online in the BMJ’s sister journal Gut (2011;60:1152-8, doi:10.1136/gut.2010.218214), although the condition was first recognised in the 1930s, named in the 1960s, and characterised histopathologically in 1980, the substantial and growing global burden from NAFLD, and its likely impact on individuals and public health, are only now becoming clear.

Once a curiosity for …

View Full Text